Atreca Inc (BCEL)
0.092
0.00 (0.00%)
USD |
OTCM |
May 15, 15:19
Atreca Total Assets (Quarterly): 26.34M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 26.34M |
| June 30, 2023 | 115.07M |
| March 31, 2023 | 134.43M |
| December 31, 2022 | 155.03M |
| September 30, 2022 | 172.08M |
| June 30, 2022 | 190.83M |
| March 31, 2022 | 213.69M |
| December 31, 2021 | 200.06M |
| September 30, 2021 | 220.26M |
| June 30, 2021 | 240.84M |
| Date | Value |
|---|---|
| March 31, 2021 | 261.80M |
| December 31, 2020 | 272.06M |
| September 30, 2020 | 275.19M |
| June 30, 2020 | 164.54M |
| March 31, 2020 | 178.97M |
| December 31, 2019 | 195.72M |
| September 30, 2019 | 212.72M |
| June 30, 2019 | 227.38M |
| March 31, 2019 | 109.13M |
| December 31, 2018 | 121.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
26.34M
Minimum
Sep 2023
275.19M
Maximum
Sep 2020
192.06M
Average
197.89M
Median
Total Assets (Quarterly) Benchmarks
| Catalent Inc | 9.879B |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 48.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.58M |
| Shareholders Equity (Quarterly) | 10.76M |